Table 2.
Comparison of clinicopathological characteristics between two groups stratified by CA125 level (n = 427).
| Characteristics | CA125 ≤30 U/mL (n = 392) | CA125 >30 U/mL (n = 35) | P |
|---|---|---|---|
| Age (years) (≤65/>65) | 325/67 | 31/4 | 0.389 |
| Gender (male/female) | 340/52 | 26/9 | 0.044 |
| Cirrhosis (yes/No) | 335/57 | 31/4 | 0.614 |
| Virus hepatitis (HBV/HCV/non-HBV, non-HCV) | 332/8/52 | 27/0/8 | 0.184 |
| Child-Pugh (A/B) | 383/9 | 32/3 | 0.074 |
| ALT (U/L) (≤60/>60) | 323/69 | 30/5 | 0.619 |
| T-Bil (Umol/L) (≤20/>20) | 304/88 | 26/9 | 0.659 |
| Anatomical resection (yes/no) | 130/262 | 16/19 | 0.134 |
| Surgical margin (mm) (≤10/>10) | 335/57 | 29/6 | 0.677 |
| MTD (cm) (≤5/>5) | 307/85 | 13/22 | <0.001 |
| Number of nodules (1/>1) | 332/60 | 31/4 | 0.538 |
| Microvascular invasion (yes/no) | 82/310 | 9/26 | 0.507 |
| Differentiation (well/mod, poor) | 48/344 | 2/33 | 0.381 |
| TNM stage∗ | |||
| I | 304 | 24 | 0.115 |
| II | 56 | 4 | |
| III | 32 | 7 |
HBV, viral hepatitis B; HCV, viral hepatitis C; ALT, alanine transaminase; T-Bil, total bilirubin; MTD, maximal tumor diameter; IQR, interquartile range. ∗TNM stages were assigned according to the criteria described in the AJCC Cancer Staging Manual (8th Edition).